Intrinsic Value

Alnylam Pharmaceuticals, Inc. (ALNY)

$149.45

-4.94 (-3.20%)

Enterprise Value -1,149,349.36
Net Debt 1,869.94
Equity Value -1,151,219.29
Shares Outstanding 124.91
Equity Value Per Share -9,216.69



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt